bluebird bio - Ownership and Business Overview

Life ScienceCompany

bluebird bio Ownership

Who owns bluebird bio?

bluebird bio is owned by SK Capital Partners and The Carlyle Group. It was acquired on February 21, 2025.

Is bluebird bio PE-backed?

Yes. bluebird bio is owned by private equity investors SK Capital Partners and The Carlyle Group.

Was bluebird bio formerly PE-backed?

Yes. bluebird bio was formerly owned by 1 private investor.

bluebird bio Business Overview

Where is bluebird bio headquartered?

bluebird bio is headquartered in Somerville, Massachusetts.

What is bluebird bio’s revenue?

bluebird bio disclosed revenue of 29M USD for 2023 and 4M USD for 2022.

How many employees does bluebird bio have?

bluebird bio has 323 employees.

What sector is bluebird bio in?

bluebird bio is a life science company.

When was bluebird bio founded?

bluebird bio was founded in 1992.

Life Science M&A Summary in 2025

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2025. The largest life science acquisition in 2025 was Intra-Cellular Therapies - which was acquired by Johnson & Johnson for $14.6B.

Join Mergr to view all 55 acquisitions of life science companies in 2025, including 3 acquisitions by private equity firms, and 52 by strategics.

bluebird bio

bluebird bio, Inc.

455 Grand Union Boulevard,
Somerville, Massachusetts 02145
United States,
(339) 499-9300
www.bluebirdbio.com

bluebird bio is a clinical-stage biotechnology company focused on transforming the lives of patients with severe genetic and orphan diseases using gene therapy. bluebird bio was founded in 1992 and is based in Somerville, Massachusetts.


 Subscribe to unlock this and 212,263
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.7K Private Equity Firms
  • 205K M&A Transactions
  • 208K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 80K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.